ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/03/2026
Voltar para busca
Dado oficial do USPTO
MESOBLAST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
29/03/2005
Data de registro
04/03/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/03/2018
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
16
Localização do titular
Victoria, AU
Examinador
BUCHANAN WILL, NORA
Unidade examinadora
M70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Mesoblast Limited
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluidscultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantationmedical and surgical purposes but not including embryonic stem cells; human cells including stem cells but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatmentreconstruction and repair of tissue but not including preparations for embryonic stem cells
Classe 42
Scientificmedical researchclinical researchpharmaceutical research and developmentadvisory and consultancy services in the field of T-cell productionT-cell immunotherapycell culture devicestissue engineering for cellular applications for humans and animalsstem cell bankingtissue bankingdrug discoveryvaccine screeningcell culture methodscell expansion technology including stem cell expansion technologycellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
16/03/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/03/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
16/03/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/03/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
02/03/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/03/2017
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/02/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/02/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/02/2014
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
05/02/2014
ES8R
TEAS SECTION 8 RECEIVED
05/02/2014
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/03/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
28/01/2008
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
28/01/2008
DMCC
DATA MODIFICATION COMPLETED
28/01/2008
ALIE
ASSIGNED TO LIE
25/01/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2007
DOCK
ASSIGNED TO EXAMINER
14/11/2007
CNRT
NON-FINAL ACTION MAILED
05/11/2007
CNRT
NON-FINAL ACTION WRITTEN
05/11/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/08/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/08/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/08/2007
CNSI
INQUIRY AS TO SUSPENSION MAILED
16/02/2007
CNSI
SUSPENSION INQUIRY WRITTEN
15/02/2007
CNSL
LETTER OF SUSPENSION MAILED
15/08/2006
CNSL
SUSPENSION LETTER WRITTEN
15/08/2006
DOCK
ASSIGNED TO EXAMINER
14/08/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
11/05/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2006
PAPER RECEIVED
24/04/2006
CNRT
NON-FINAL ACTION MAILED
31/10/2005
CNRT
NON-FINAL ACTION WRITTEN
28/10/2005
DOCK
ASSIGNED TO EXAMINER
25/10/2005
NWAP
NEW APPLICATION ENTERED
05/04/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MESOBLAST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.